Select Medical Q3 revenue up 7.2% to $1.36B, EPS $0.23; raises FY25 EPS guidance

SELECT MEDICAL HOLDINGS CORP

2025-Q3 EPS reported $1.00 revenue$4,056,196,000

Q3 revenue $1,363.4M (+7.2% YoY); income from cont ops $44.2M (+7%); Adj EBITDA $111.7M (+7.5%).
EPS from cont ops $0.23 vs $0.19 (+21.1%); adjusted EPS $0.23 vs $0.26 (-11.5%).
Rehab hospital rev +16.2% to $328.6M; outpatient rehab EBITDA margin fell to 7.4% from 9.1%.
FY25 outlook: revenue $5.3-5.5B, Adj EBITDA $510-530M, diluted EPS $1.14-1.24 (raised).
Dividend $0.0625/share declared; stock buyback program extended to Dec 31, 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.